254 related articles for article (PubMed ID: 30846479)
1. Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.
Vantaku V; Dong J; Ambati CR; Perera D; Donepudi SR; Amara CS; Putluri V; Ravi SS; Robertson MJ; Piyarathna DWB; Villanueva M; von Rundstedt FC; Karanam B; Ballester LY; Terris MK; Bollag RJ; Lerner SP; Apolo AB; Villanueva H; Lee M; Sikora AG; Lotan Y; Sreekumar A; Coarfa C; Putluri N
Clin Cancer Res; 2019 Jun; 25(12):3689-3701. PubMed ID: 30846479
[TBL] [Abstract][Full Text] [Related]
2. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
Kim WT; Yun SJ; Yan C; Jeong P; Kim YH; Lee IS; Kang HW; Park S; Moon SK; Choi YH; Choi YD; Kim IY; Kim J; Kim WJ
Yonsei Med J; 2016 Jul; 57(4):865-71. PubMed ID: 27189278
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
5. Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers.
Iliou A; Panagiotakis A; Giannopoulou AF; Benaki D; Kosmopoulou M; Velentzas AD; Tsitsilonis OE; Papassideri IS; Voutsinas GE; Konstantakou EG; Gikas E; Mikros E; Stravopodis DJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32164285
[TBL] [Abstract][Full Text] [Related]
6. Increased cardiac fatty acid oxidation in a mouse model with decreased malonyl-CoA sensitivity of CPT1B.
van Weeghel M; Abdurrachim D; Nederlof R; Argmann CA; Houtkooper RH; Hagen J; Nabben M; Denis S; Ciapaite J; Kolwicz SC; Lopaschuk GD; Auwerx J; Nicolay K; Des Rosiers C; Wanders RJ; Zuurbier CJ; Prompers JJ; Houten SM
Cardiovasc Res; 2018 Aug; 114(10):1324-1334. PubMed ID: 29635338
[TBL] [Abstract][Full Text] [Related]
7. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
Lu X; Zhang X; Zhang Y; Zhang K; Zhan C; Shi X; Li Y; Zhao J; Bai Y; Wang Y; Nie H; Li Y
Mol Carcinog; 2019 May; 58(5):749-759. PubMed ID: 30604893
[TBL] [Abstract][Full Text] [Related]
9. Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.
Amara CS; Ambati CR; Vantaku V; Badrajee Piyarathna DW; Donepudi SR; Ravi SS; Arnold JM; Putluri V; Chatta G; Guru KA; Badr H; Terris MK; Bollag RJ; Sreekumar A; Apolo AB; Putluri N
Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):770-781. PubMed ID: 30642841
[TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
11. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the metabolomic study of bladder cancer.
Amara CS; Vantaku V; Lotan Y; Putluri N
Expert Rev Proteomics; 2019 Apr; 16(4):315-324. PubMed ID: 30773067
[TBL] [Abstract][Full Text] [Related]
13. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.
Celis JE; Ostergaard M; Basse B; Celis A; Lauridsen JB; Ratz GP; Andersen I; Hein B; Wolf H; Orntoft TF; Rasmussen HH
Cancer Res; 1996 Oct; 56(20):4782-90. PubMed ID: 8840999
[TBL] [Abstract][Full Text] [Related]
14. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-focused gene expression profile reveals common pathways and CPT1B dysregulation in both rodent stress model and human subjects with PTSD.
Zhang L; Li H; Hu X; Benedek DM; Fullerton CS; Forsten RD; Naifeh JA; Li X; Wu H; Benevides KN; Le T; Smerin S; Russell DW; Ursano RJ
Transl Psychiatry; 2015 Jun; 5(6):e580. PubMed ID: 26080315
[TBL] [Abstract][Full Text] [Related]
16. Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity.
Maples JM; Brault JJ; Witczak CA; Park S; Hubal MJ; Weber TM; Houmard JA; Shewchuk BM
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E345-56. PubMed ID: 26058865
[TBL] [Abstract][Full Text] [Related]
17. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
18. A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
van Kessel KE; van de Werken HJ; Lurkin I; Ziel-van der Made AC; Zwarthoff EC; Boormans JL
PLoS One; 2017; 12(3):e0174039. PubMed ID: 28319171
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
Rodrigues D; Jerónimo C; Henrique R; Belo L; de Lourdes Bastos M; de Pinho PG; Carvalho M
Int J Cancer; 2016 Jul; 139(2):256-68. PubMed ID: 26804544
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
